Dose Reduction in Brain [18F]FDG PET/MRI: Give It Half a Chance
- 8 July 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Imaging & Biology
- Vol. 22 (3), 695-702
- https://doi.org/10.1007/s11307-019-01398-3
Abstract
Integrated positron emission tomography (PET)/magnetic resonance imaging (MRI) offers promising tools for evaluating brain disorders, including the minimization of exposure to ionizing radiation. Considering the length of scanning time with PET/MRI systems and their high sensitivity, we assumed that the activity could be reduced by one half compared with recommended activity for brain 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) PET exams without degrading image quality.Keywords
This publication has 28 references indexed in Scilit:
- Motion Correction Options in PET/MRISeminars in Nuclear Medicine, 2015
- PET/MR in Dementia and Other Neurodegenerative DiseasesSeminars in Nuclear Medicine, 2015
- Update on Time-of-Flight PET ImagingJournal of Nuclear Medicine, 2014
- Radiotracer Dose Reduction in Integrated PET/MR: Implications from National Electrical Manufacturers Association Phantom StudiesJournal of Nuclear Medicine, 2014
- PET and MR Imaging: The Odd Couple or a Match Made in Heaven?Journal of Nuclear Medicine, 2013
- Clinical impact of time-of-flight and point response modeling in PET reconstructions: a lesion detection studyPhysics in Medicine & Biology, 2013
- Physical and clinical performance of the mCT time-of-flight PET/CT scannerPhysics in Medicine & Biology, 2011
- EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2European Journal of Nuclear Medicine and Molecular Imaging, 2009
- 3-D phantom to simulate cerebral blood flow and metabolic images for PETIEEE Transactions on Nuclear Science, 1990
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986